Back to Agenda
Australia, Canada, Singapore, Switzerland, and United Kingdom Consortium (Access): Re-Imagining Regulatory Collaboration
Session Chair(s)
Pamela Aung-Thin
Assistant Deputy Minister of the Health Products and Food Branch
Health Canada, Canada
Established in 2007, the Access Consortium brings together like-minded regulatory agencies to promote regulatory convergence and foster synergy to address scientific and regulatory issues. In this session, leaders from the Access Consortium will provide an update on achievements using work-sharing initiatives for timely medicines approvals for our populations, enabling industry to bring new, innovative products through Access pathways.
Learning Objective : Discuss pathways and opportunities for industry to bring innovative products through Access; Describe new tools and methodologies to optimize regulatory collaboration under the Access Consortium to support access to medicines.
Speaker(s)
Panelist
Alison Cave, PhD
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Chief Safety Officer
Panelist
Anthony Lawler, MD, MBA
Therapeutic Goods Administration, Australia
Deputy Secretary, Health Products Regulation Group
Panelist
Mimi May Ling Choong, DrMed, MD
Health Sciences Authority (HSA), Singapore
Chief Executive Officer
Panelist
Jörg Schläpfer, PhD
Swissmedic, Switzerland
Head of Management Services and International Affairs
Panelist
Eveline Trachsel
Swissmedic, Switzerland
Head of Medicinal Product Authorisation and Vigilance
Have an account?